1. Home
  2. MHO vs TMDX Comparison

MHO vs TMDX Comparison

Compare MHO & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MHO

M/I Homes Inc.

HOLD

Current Price

$127.65

Market Cap

3.3B

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$111.80

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHO
TMDX
Founded
1976
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
MHO
TMDX
Price
$127.65
$111.80
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$160.00
$148.22
AVG Volume (30 Days)
172.4K
851.2K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
382.18
EPS
14.74
4.87
Revenue
$4,417,781,000.00
$605,494,000.00
Revenue This Year
$0.66
$24.51
Revenue Next Year
$6.97
$18.72
P/E Ratio
$8.57
$23.79
Revenue Growth
N/A
37.13
52 Week Low
$102.44
$88.50
52 Week High
$158.92
$156.00

Technical Indicators

Market Signals
Indicator
MHO
TMDX
Relative Strength Index (RSI) 53.54 48.73
Support Level $125.38 $109.43
Resistance Level $127.81 $131.86
Average True Range (ATR) 3.63 5.27
MACD 1.01 1.93
Stochastic Oscillator 91.47 67.41

Price Performance

Historical Comparison
MHO
TMDX

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprises a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: